Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;102:1216-1220

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jaffe, A. S.
Right arrow Articles by Katus, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jaffe, A. S.
Right arrow Articles by Katus, H.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Related Collections
Right arrow Acute coronary syndromes
Right arrow Other diagnostic testing
Right arrow Acute myocardial infarction

(Circulation. 2000;102:1216.)
© 2000 American Heart Association, Inc.


Editorial

It’s Time for a Change to a Troponin Standard

Allan S. Jaffe, MD; Jan Ravkilde, MD, DMSc; Robert Roberts, MD; Ulf Naslund, MD, PhD; Fred S. Apple, PhD; Marcello Galvani, MD; Hugo Katus, MD, PhD

From the Mayo Clinic, Rochester, Minn (A.S.J.); Aalborg University Hospital, Aalborg, Denmark (J.R.); Baylor College of Medicine, Houston, Tex (R.R.); Norrland University Hospital, Umea, Sweden (U.N.); Hennepin County Medical Center and the University of Minnesota, Minneapolis (F.S.A.); Ospedale G.B. Morgagni and Fondazione Cardiologica Sacco, Forlì, Italy (M.G.); and Universitat zu Lubeck, Lubeck, Germany (H.K.).

Correspondence Allan S. Jaffe, MD, 16th Floor, Mayo Building, 200 First Street SW, Rochester, MN 55905. E-mail Jaffe.Allan@mayo.edu


Key Words: Editorials • troponin • myocardial infarction • coronary disease

Recently, the European Society of Cardiology (ESC) and the American College of Cardiology (ACC) convened a conference to discuss refinements in the diagnosis of acute myocardial infarction. The panel on biochemistry considered issues related to the use of marker proteins. We were guided predominantly by the science of the area. We were also cognizant of the impact that changes in the standards would have on epidemiology, clinical trials, education of physicians, and patient care. Our recommendations will be incorporated, with the recommendations of the other panels, into a position paper for the ESC and the ACC. However, the members of the biochemistry group decided to express the opinions we felt were important in this area independently. Our thinking does not represent the position of the ESC, the ACC, or of the conjoint task force.

Many modifications of the original World Health Organization criteria for acute myocardial infarction1 have been accepted and incorporated into the ESC/ACC criteria; some deletions have also occurred. Until recently, most markers were detected using enzymatic activity; detection of the protein concentration now is preferred. Thus, it is more appropriate to refer to molecules released into the circulation as a consequence of cardiac injury as biochemical diagnostic markers or biomarkers. In this editorial, we emphasize issues related to the biochemical diagnosis of acute myocardial infarction. New and improved plasma biomarkers (troponins) with better sensitivity and specificity will be emphasized in preference to markers such as total creatine kinase (CK), CK-MB, lactate dehydrogenase, and aspartate aminotransferase. Rapid assays . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
Asian Cardiovasc. Thorac. Ann.Home page
C. Simon, F. Capuano, A. Roscitano, U. Benedetto, C. Comito, and R. Sinatra
Cardiac Troponin I vs EuroSCORE: Myocardial Infarction and Hospital Mortality
Asian Cardiovasc Thorac Ann, April 1, 2008; 16(2): 97 - 102.
[Abstract] [Full Text] [PDF]


Home page
Asian Cardiovasc. Thorac. Ann.Home page
F. Capuano, C. Simon, A. Roscitano, G. Sclafani, E. Tonelli, and R. Sinatra
Cardiac Troponin I Concentrations During On-Pump Coronary Artery Surgery
Asian Cardiovasc Thorac Ann, December 1, 2007; 15(6): 502 - 506.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
K. Thygesen, J. S. Alpert, H. D. White, and on behalf of the Joint ESC/ACCF/AHA/WHF Task Force
Universal Definition of Myocardial Infarction
J. Am. Coll. Cardiol., November 27, 2007; 50(22): 2173 - 2195.
[Full Text] [PDF]


Home page
CirculationHome page
K. Thygesen, J. S. Alpert, H. D. White, on behalf of the Joint ESC/ACCF/AHA/WHF Task Force, TASK FORCE MEMBERS: Chairpersons: Kristian Thygese, Biomarker Group: Allan S. Jaffe, Coordinator (USA), ECG Group: Bernard Chaitman, Co-ordinator (USA), P, Imaging Group: Richard Underwood, Coordinator (UK), Intervention Group: Jean-Pierre Bassand, Co-ordina, Clinical Investigation Group: Paul W. Armstrong, C, et al.
Universal Definition of Myocardial Infarction
Circulation, November 27, 2007; 116(22): 2634 - 2653.
[Full Text] [PDF]


Home page
Eur Heart JHome page
Task Force Members, K. Thygesen, J. S. Alpert, H. D. White, Biomarker Group, A. S. Jaffe, F. S. Apple, M. Galvani, H. A. Katus, L. K. Newby, et al.
Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
Eur. Heart J., October 2, 2007; 28(20): 2525 - 2538.
[Full Text] [PDF]


Home page
CirculationHome page
NACB Writing Group Members, F. S. Apple, R. L. Jesse, L. K. Newby, A. H.B. Wu, and R. H. Christenson
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biochemical Markers of Acute Coronary Syndromes
Circulation, April 3, 2007; 115(13): e352 - e355.
[Full Text] [PDF]


Home page
CirculationHome page
NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, and R. H. Christenson
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes
Circulation, April 3, 2007; 115(13): e356 - e375.
[Full Text] [PDF]


Home page
QJMHome page
P. Mad, H. Domanovits, C. Fazelnia, K. Stiassny, G. Russmuller, A. Cseh, G. Sodeck, T. Binder, G. Christ, T. Szekeres, et al.
Human heart-type fatty-acid-binding protein as a point-of-care test in the early diagnosis of acute myocardial infarction
QJM, April 1, 2007; 100(4): 203 - 210.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
NACB WRITING GROUP MEMBERS, D. A. Morrow, C. P. Cannon, R. L. Jesse, L. K. Newby, J. Ravkilde, A. B. Storrow, A. H.B. Wu, R. H. Christenson, NACB COMMITTEE MEMBERS, et al.
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Characteristics and Utilization of Biochemical Markers in Acute Coronary Syndromes
Clin. Chem., April 1, 2007; 53(4): 552 - 574.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
NACB WRITING GROUP MEMBERS, F. S. Apple, R. L. Jesse, L. K. Newby, A. H.B. Wu, R. H. Christenson, NACB COMMITTEE MEMBERS, R. H. Christenson, F. S. Apple, C. P. Cannon, et al.
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biochemical Markers of Acute Coronary Syndromes
Clin. Chem., April 1, 2007; 53(4): 547 - 551.
[Full Text] [PDF]


Home page
CirculationHome page
P. D. Thompson, F. S. Apple, and A. Wu
Marathoner's Heart?
Circulation, November 28, 2006; 114(22): 2306 - 2308.
[Full Text] [PDF]


Home page
CirculationHome page
A. H.B. Wu
Cardiac Troponin: Friend of the Cardiac Physician, Foe to the Cardiac Patient?
Circulation, October 17, 2006; 114(16): 1673 - 1675.
[Full Text] [PDF]


Home page
CirculationHome page
T. Sommer, C. P. Naehle, A. Yang, V. Zeijlemaker, M. Hackenbroch, A. Schmiedel, C. Meyer, K. Strach, D. Skowasch, C. Vahlhaus, et al.
Strategy for Safe Performance of Extrathoracic Magnetic Resonance Imaging at 1.5 Tesla in the Presence of Cardiac Pacemakers in Non-Pacemaker-Dependent Patients: A Prospective Study With 115 Examinations
Circulation, September 19, 2006; 114(12): 1285 - 1292.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. S. Jaffe, L. Babuin, and F. S. Apple
Biomarkers in Acute Cardiac Disease: The Present and the Future
J. Am. Coll. Cardiol., July 4, 2006; 48(1): 1 - 11.
[Abstract] [Full Text] [PDF]


Home page
Br. J. Sports. Med.Home page
L Tulloh, D Robinson, A Patel, A Ware, C Prendergast, D Sullivan, and L Pressley
Raised troponin T and echocardiographic abnormalities after prolonged strenuous exercise--the Australian Ironman Triathlon
Br. J. Sports Med., July 1, 2006; 40(7): 605 - 609.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
W. L. Miller, K. N. Garratt, M. F. Burritt, R. J. Lennon, G. S. Reeder, and A. S. Jaffe
Baseline troponin level: key to understanding the importance of post-PCI troponin elevations
Eur. Heart J., May 1, 2006; 27(9): 1061 - 1069.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
F. S. Apple, R. Ler, A. Y. Chung, M. J. Berger, and M. M. Murakami
Point-of-Care i-STAT Cardiac Troponin I for Assessment of Patients with Symptoms Suggestive of Acute Coronary Syndrome,
Clin. Chem., February 1, 2006; 52(2): 322 - 325.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
F. S. Apple
Clinical Biomarkers of Cardiac Injury: Cardiac Troponins and Natriuretic Peptides
Toxicol Pathol, January 1, 2006; 34(1): 91 - 93.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
L. Babuin and A. S. Jaffe
Troponin: the biomarker of choice for the detection of cardiac injury
Can. Med. Assoc. J., November 8, 2005; 173(10): 1191 - 1202.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
D. Paparella, G. Cappabianca, G. Visicchio, A. Galeone, A. Marzovillo, N. Gallo, C. Memmola, and L. d. L. T. Schinosa
Cardiac Troponin I Release After Coronary Artery Bypass Grafting Operation: Effects on Operative and Midterm Survival
Ann. Thorac. Surg., November 1, 2005; 80(5): 1758 - 1764.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
F. S. Apple, C. A. Parvin, K. F. Buechler, R. H. Christenson, A. H.B. Wu, and A. S. Jaffe
Validation of the 99th Percentile Cutoff Independent of Assay Imprecision (CV) for Cardiac Troponin Monitoring for Ruling Out Myocardial Infarction
Clin. Chem., November 1, 2005; 51(11): 2198 - 2200.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
M. T. Roe, E. D. Peterson, Y. Li, C. V. Pollack Jr, R. H. Christenson, W. F. Peacock, F. M. Fesmire, L. K. Newby, R. L. Jesse, J. W. Hoekstra, et al.
Relationship Between Risk Stratification by Cardiac Troponin Level and Adherence to Guidelines for Non-ST-Segment Elevation Acute Coronary Syndromes
Arch Intern Med, September 12, 2005; 165(16): 1870 - 1876.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Panteghini
Standardization of Cardiac Troponin I Measurements: The Way Forward?
Clin. Chem., September 1, 2005; 51(9): 1594 - 1597.
[Full Text] [PDF]


Home page
CMAJHome page
M. S. Sabatine
When prognosis precedes diagnosis: putting the cart before the horse
Can. Med. Assoc. J., June 21, 2005; 172(13): 1697 - 1698.
[Full Text] [PDF]


Home page
CirculationHome page
W. B. Gibler, C. P. Cannon, A. L. Blomkalns, D. M. Char, B. J. Drew, J. E. Hollander, A. S. Jaffe, R. L. Jesse, L. K. Newby, E. M. Ohman, et al.
Practical Implementation of the Guidelines for Unstable Angina/Non-ST-Segment Elevation Myocardial Infarction in the Emergency Department: A Scientific Statement From the American Heart Association Council on Clinical Cardiology (Subcommittee on Acute Cardiac Care), Council on Cardiovascular Nursing, and Quality of Care and Outcomes Research Interdisciplinary Working Group, in Collaboration With the Society of Chest Pain Centers
Circulation, May 24, 2005; 111(20): 2699 - 2710.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
D. Duman, S. Tokay, A. Toprak, D. Duman, A. Oktay, and I. C. Ozener
Elevated cardiac troponin T is associated with increased left ventricular mass index and predicts mortality in continuous ambulatory peritoneal dialysis patients
Nephrol. Dial. Transplant., May 1, 2005; 20(5): 962 - 967.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Panteghini
Selection of Antibodies and Epitopes for Cardiac Troponin Immunoassays: Should We Revise Our Evidence-Based Beliefs?
Clin. Chem., May 1, 2005; 51(5): 803 - 804.
[Full Text] [PDF]


Home page
QJMHome page
C.E. Burness, D. Beacock, and K.S. Channer
Pitfalls and problems of relying on serum troponin
QJM, May 1, 2005; 98(5): 365 - 371.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
R. Luechinger, V. A. Zeijlemaker, E. M. Pedersen, P. Mortensen, E. Falk, F. Duru, R. Candinas, and P. Boesiger
In vivo heating of pacemaker leads during magnetic resonance imaging
Eur. Heart J., February 2, 2005; 26(4): 376 - 383.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. Ramsay, S. Shernan, J. Fitch, P. Finnegan, T. Todaro, T. Filloon, and N. A. Nussmeier
Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves
J. Thorac. Cardiovasc. Surg., February 1, 2005; 129(2): 300 - 306.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
F. S. Apple and M. M. Murakami
Cardiac Troponin and Creatine Kinase MB Monitoring during In-Hospital Myocardial Reinfarction
Clin. Chem., February 1, 2005; 51(2): 460 - 463.
[Full Text] [PDF]


Home page
Anesth. Analg.Home page
S. Mierdl, C. Byhahn, V. Lischke, T. Aybek, G. Wimmer-Greinecker, S. Dogan, S. Viehmeyer, P. Kessler, and K. Westphal
Segmental Myocardial Wall Motion During Minimally Invasive Coronary Artery Bypass Grafting Using Open and Endoscopic Surgical Techniques
Anesth. Analg., February 1, 2005; 100(2): 306 - 314.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
R. F. Salamonsen, H.-G. Schneider, M. Bailey, and A. J. Taylor
Cardiac Troponin I Concentrations, but Not Electrocardiographic Results, Predict an Extended Hospital Stay after Coronary Artery Bypass Graft Surgery
Clin. Chem., January 1, 2005; 51(1): 40 - 46.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
F. S. Apple, M. M. Murakami, L. A. Pearce, and C. A. Herzog
Multi-Biomarker Risk Stratification of N-Terminal Pro-B-Type Natriuretic Peptide, High-Sensitivity C-Reactive Protein, and Cardiac Troponin T and I in End-Stage Renal Disease for All-Cause Death
Clin. Chem., December 1, 2004; 50(12): 2279 - 2285.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. T. Yan, R. T. Yan, M. Tan, C.-M. Chow, D. Fitchett, E. Stanton, A. Langer, S. G. Goodman, and for the Canadian Acute Coronary Syndromes Registr
Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patients
Eur. Heart J., November 2, 2004; 25(22): 2006 - 2012.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
Y Sato, T Kita, Y Takatsu, and T Kimura
Biochemical markers of myocyte injury in heart failure
Heart, October 1, 2004; 90(10): 1110 - 1113.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
A. Dispenzieri, M. A. Gertz, R. A. Kyle, M. Q. Lacy, M. F. Burritt, T. M. Therneau, P. R. Greipp, T. E. Witzig, J. A. Lust, S. V. Rajkumar, et al.
Serum Cardiac Troponins and N-Terminal Pro-Brain Natriuretic Peptide: A Staging System for Primary Systemic Amyloidosis
J. Clin. Oncol., September 15, 2004; 22(18): 3751 - 3757.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Dispenzieri, M. A. Gertz, R. A. Kyle, M. Q. Lacy, M. F. Burritt, T. M. Therneau, J. P. McConnell, M. R. Litzow, D. A. Gastineau, A. Tefferi, et al.
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
Blood, September 15, 2004; 104(6): 1881 - 1887.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
A. S. Jaffe, F. S. Apple, and L. Babuin
Why We Don't Know the Answer May Be More Important than the Specific Question
Clin. Chem., September 1, 2004; 50(9): 1495 - 1497.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
F. S. Apple and M. M. Murakami
Serum 99th Percentile Reference Cutoffs for Seven Cardiac Troponin Assays
Clin. Chem., August 1, 2004; 50(8): 1477 - 1479.
[Full Text] [PDF]


Home page
Eur Heart JHome page
M. Panteghini
Role and importance of biochemical markers in clinical cardiology
Eur. Heart J., July 2, 2004; 25(14): 1187 - 1196.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
M. Kemp, J. Donovan, H. Higham, and J. Hooper
Biochemical markers of myocardial injury
Br. J. Anaesth., July 1, 2004; 93(1): 63 - 73.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. S. Gami, A. Svatikova, R. Wolk, E. J. Olson, C. J. Duenwald, A. S. Jaffe, and V. K. Somers
Cardiac Troponin T in Obstructive Sleep Apnea
Chest, June 1, 2004; 125(6): 2097 - 2100.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
C. Roongsritong, I. Warraich, and C. Bradley
Common Causes of Troponin Elevations in the Absence of Acute Myocardial Infarction: Incidence and Clinical Significance
Chest, May 1, 2004; 125(5): 1877 - 1884.
[Abstract] [Full Text] [PDF]


Home page
JRSMHome page
D. J Fox, C. Grimm, and N. P Curzen
Raised troponin T in acute cholecystitis
J R Soc Med, April 1, 2004; 97(4): 179 - 179.
[Full Text] [PDF]


Home page
Eur Heart J SupplHome page
E. M Antman
The re-emergence of anticoagulation in coronary disease
Eur. Heart J. Suppl., April 1, 2004; 6(suppl_B): B2 - B8.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. C. Kontos, R. Shah, L. M. Fritz, F. P. Anderson, J. L. Tatum, J. P. Ornato, and R. L. Jesse
Implication of different cardiac troponin I levels for clinical outcomes and prognosis of acute chest pain patients
J. Am. Coll. Cardiol., March 17, 2004; 43(6): 958 - 965.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
W B Borke, B H Munkeby, L Morkrid, E Thaulow, and O D Saugstad
Resuscitation with 100% O2 does not protect the myocardium in hypoxic newborn piglets
Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2004; 89(2): F156 - F160.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
M. Panteghini, F. Pagani, K.-T. J. Yeo, F. S. Apple, R. H. Christenson, F. Dati, J. Mair, J. Ravkilde, and A. H.B. Wu
Evaluation of Imprecision for Cardiac Troponin Assays at Low-Range Concentrations
Clin. Chem., February 1, 2004; 50(2): 327 - 332.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
J. C. Lin, F. S. Apple, M. M. Murakami, and R. V. Luepker
Rates of Positive Cardiac Troponin I and Creatine Kinase MB Mass among Patients Hospitalized for Suspected Acute Coronary Syndromes
Clin. Chem., February 1, 2004; 50(2): 333 - 338.
[Abstract] [Full Text] [PDF]


Home page
Toxicol PatholHome page
K. B. Wallace, E. Hausner, E. Herman, G. D. Holt, J. T. Macgregor, A. L. Metz, E. Murphy, I.Y. Rosenblum, F. D. Sistare, and M. J. York
Serum Troponins as Biomarkers of Drug-Induced Cardiac Toxicity
Toxicol Pathol, January 1, 2004; 32(1): 106 - 121.
[PDF]


Home page
ChestHome page
W. L. Miller, K. N. Garratt, M. F. Burritt, G. S. Reeder, and A. S. Jaffe
Timing of Peak Troponin T and Creatine Kinase-MB Elevations After Percutaneous Coronary Intervention
Chest, January 1, 2004; 125(1): 275 - 280.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
A. S. Jaffe
A small step for man, a leap forward for postoperative management
J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1555 - 1557.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
E. Giannitsis and H. A. Katus
99th Percentile and Analytical Imprecision of Troponin and Creatine Kinase-MB Mass Assays: An Objective Platform for Comparison of Assay Performance
Clin. Chem., August 1, 2003; 49(8): 1248 - 1249.
[Full Text] [PDF]


Home page
Clin. Chem.Home page
F. S. Apple, H. E. Quist, P. J. Doyle, A. P. Otto, and M. M. Murakami
Plasma 99th Percentile Reference Limits for Cardiac Troponin and Creatine Kinase MB Mass for Use with European Society of Cardiology/American College of Cardiology Consensus Recommendations
Clin. Chem., August 1, 2003; 49(8): 1331 - 1336.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
D. A. Morrow, N. Rifai, M. S. Sabatine, S. Ayanian, S. A. Murphy, J. A. de Lemos, E. Braunwald, and C. P. Cannon
Evaluation of the AccuTnI Cardiac Troponin I Assay for Risk Assessment in Acute Coronary Syndromes
Clin. Chem., August 1, 2003; 49(8): 1396 - 1398.
[Full Text] [PDF]